Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck describes new selective androgen receptor modulators for osteoporosis therapy

Dec. 22, 2003

Oxycyte studied for cardiac surgery

Dec. 19, 2003

New clinical study evaluates SEPA-enhanced testosterone

Dec. 19, 2003

APD-356 completes preclinical testing

Dec. 19, 2003

Chugai researchers discover novel biguanide-based antidiabetic agents

Dec. 19, 2003

Kirin Brewery patent covers M-CSF inhibitors able to prevent bone metastasis and osteoporosis

Dec. 19, 2003

Xenical approved for obese adolescents

Dec. 18, 2003

SomatoKine granted orphan drug designation for extreme insulin resistance

Dec. 18, 2003

Niaspan and Advicor filed for marketing approval in Canada

Dec. 17, 2003

Generex and Acertus to develop oral recombinant human growth hormone

Dec. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...